pharma · Chronic Atrophic Gastritis
Shandong Provincial Hospital drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Shandong Provincial Hospital drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Antineoplastic and immunomodulating agents (L03) compound in Shandong Provincial Hospital's portfolio. Mechanism: Somatic cell supplemental therapy.
Development asset linked to Shandong Provincial Hospital in public FDA and regional records.
Development asset linked to Shandong Provincial Hospital in public FDA and regional records.